Published Date: 02 Feb 2024
B-cell malignancies, B-cell treatments associated with longer duration of infection.
Read Full News1.
Researchers identify potential new therapeutic targets for treating T-cell lymphoma and natural killer cell tumors.
2.
Urinary tract cancer prediction models with high sensitivity and specificity
3.
Treatment of Oligometastatic EGFR-Mutant Lung Cancer
4.
In leukemia, allogeneic HCT is beneficial following primary induction failure.
5.
Updates from the 2022 WHO classification of kidney epithelial tumors
1.
Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies
2.
Driving Impact: Oncology Pharmaceutical Marketing Strategies in the USA
3.
Unraveling the Genetic Mystery of Hereditary Spherocytosis
4.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
5.
The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
2.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
4.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
5.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation